CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Teal won FDA approval for a self-collection device after running a study at 16 sites in the U.S. Writing in the JAMA paper, ...

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed ...

The company will compete with a device Boston Scientific acquired for $850 million.

“For too long, Johnson & Johnson has used tying arrangements and other tactics to interfere with fair competition from ...

The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, ...

Many companies forecast specific tariff charges. Then the White House and China agreed to a 90-day pause in their trade ...

While venture funding is rising, federal policy upheaval may affect women’s health research more acutely than other fields, ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Vicarious Surgical and SS Innovations marked progress toward bringing their robotic surgery systems to the U.S. market. The ...

The biotech, which has for years invested in genetics research, plans to acquire "substantially all" of testing firm ...